Values of the core set variables in the 111 patients with JCA at the beginning and after six months of MTX treatment
| Baseline | After six months | |
|---|---|---|
| MD global (no of patients) | ||
| class 1 | 0 | 31 |
| class 2 | 0 | 39 |
| class 3 | 36 | 24 |
| class 4 | 50 | 8 |
| class 5 | 25 | 9 |
| Parent global (no of patients)1-150 | ||
| better | — | 80 |
| same | — | 20 |
| worse | — | 11 |
| Functional ability (mean (SD)) | 0.7 (0.7) | 0.3 (0.5) |
| No of joints with LROM (mean (SD)) | 14 (12) | 10 (12) |
| No of joints with active arthritis (mean (SD)) | 15 (11) | 10 (10) |
| ESR (mm 1st h) (mean (SD)) | 58 (30) | 35 (28) |
↵1-150 Parent global assessment of overall well being was not quantified at baseline (see text for explanation). LROM: limited range of motion; ESR: erythrocyte sedimentation rate.